Well, my May 2015 tranche has less than a month to go. It has been a massive wreck. It started poorly, with KORS getting slammed early on. Ironically, KORS battled back while everything else pretty much fell off the table.
It is down an ugly 25%. It will be my 12th tranche to close. And it is easily my worst. -14% from the February 2015 tranche is my only other absolute loser on the MFI select side.
Tough Time To Start
Part of it was just bad timing. May 2015 was a bad time to be starting an MFI portfolio. My tracking portfolios of 50 MFI stocks that bracket this tranche are each down about 17%. The ten stocks I rejected, are down about 14% (only two in the green, with ANIK being the big winner, up 41%). And the five stocks I sold are down 18% in aggregate. So again, a tough environment. But the eagle eyed reader will note I managed to do WORSE than all these comparables. Not good.
|5/6/2015||Start||Current||Dividend||Pct Gain||R3K Gain|
It definitely hurt having two pharma/bio pharma type stocks (DEPO and PSDV) at a point in time that in retrospect was near a top. Looking back, PSDV actually traded at $4.80 to start 2016. So it only recently crashed and burned. DEPO climbed into the low 30s in July and August with HZNP bid. I was feeling like a stock market genius.
I still like CBI and will likely rebalance and hold. I believe they can get back to $50 with some sort of normalization of oil prices. I also like TSRA at this price. KORS will likely be sold.
So I will need at least 3 stocks. Still too early to decide on specific names. But in micro cap names, I like BLBD and EFOI. I also like IQNT and BRCD. UTHR is a very intriguing name if it stays cheap. AMAG also.
Whatever five stocks I pick, I am hopefully not to have the 25 point variance with the benchmark noted in the table. That is beyond horrific.
I travel tomorrow to Europe. I will try to squeeze in a weekly update. Have a great weekend everyone, New England is in full beautiful Spring mode!